At a glance
ClinicalIndex Comparison RecordN/ACompleted· 188 enrolled
Drug / intervention
Acuvue Oasys 1 Day for Astigmatism +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore
In Brief
A clinical study evaluating Acuvue Oasys 1 Day for Astigmatism and TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore for Visual Acuity. Completed, enrolled 188 participants across 10 sites.
Detailed Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treatment, 2-sequence, 2-period crossover study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
First PostedMar 2023
Primary CompletionMay 2023
TodayJul 2026
First PostedMar 21, 2023
Enrollment StartMar 13, 2023
Primary CompletionMay 24, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.3 years ago
Interventions
Acuvue Oasys 1 Day for Astigmatismdevice
CONTROL
TRA100/TRA200 series toric contact lens with HEVL-blocking chromophoredevice
TEST